ORIGINAL RESEARCHAccepted on 01 Sep 2025Cholesterol Metabolic Reprogramming Drives the Onset of DLBCL and Represents a Promising Therapeutic TargetLili ZhouWei ChengDan LuoZhida PengJiaqi MeiQing-Qing LuoTiantian YuYa WangZhixiang Lei3 more Li Yudoi 10.3389/fcell.2025.1585521
Published inFrontiers in Cell and Developmental Biology Cancer Cell Biology4.3 impact factor11.4 citescore